An emerging Aussie MedTec helping the world deliver care.

For this ‘fundamental’ view on a stock, I delve deep into the depths of the smaller cap realm. It's an ‘emerging’ story that still carries elevated risks, as evidenced by the moderate overall StockRank score. These risks however seem to be moderating as the business continues its growth trajectory and hence why it has been put forward for discussion.
ASX:ALC Alcidion Group
Alcidion (ASX:ALC) assists healthcare organisations by delivering a platform which helps with patient care delivery through clinical decision support, artificial intelligence and real-time visualisation health informatics. These insights extend the full scope of patient care though to organisation management.
Miya Precision is the flagship product, and it is built on a Fast Healthcare Interoperability Resource (FHIR) standard for sharing healthcare information in a compliant manner which helps with patient management. The short description, it is a patient management system for hospitals and medical facilities.

A more simple explanation is that the platform is plugged into the electronic medical record system of a hospital and Miya helps by running clinical decision support algorithms in response to changing clinical data. There are also a range of other products and services that run from the core technology, adding...